1162582005: Brincidofovir (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Brincidofovir (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Brincidofovir (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Brincidofovir (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Brincidofovir (substance)
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Brincidofovir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4590253012 Brincidofovir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4590254018 Brincidofovir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brincidofovir (substance)	Is a	Pyrimidine and/or pyrimidine derivative	true	Inferred relationship	Some
Brincidofovir (substance)	Is a	Substance with antiviral mechanism of action (substance)	true	Inferred relationship	Some
Brincidofovir (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiviral (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only brincidofovir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brincidofovir (substance)	Inferred relationship	Some	1
Brincidofovir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brincidofovir (substance)	Inferred relationship	Some	1
Brincidofovir only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brincidofovir (substance)	Inferred relationship	Some	1
Brincidofovir-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brincidofovir (substance)	Inferred relationship	Some	1
Product containing precisely brincidofovir 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brincidofovir (substance)	Inferred relationship	Some	1
Product containing precisely brincidofovir 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brincidofovir (substance)	Inferred relationship	Some	1
Brincidofovir 10 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brincidofovir (substance)	Inferred relationship	Some	1
Brincidofovir 10 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brincidofovir (substance)	Inferred relationship	Some	1

This concept is not in any reference sets